Ask Warren

ilShinbiobase

068330 · KOSDAQ · ₩068330 · 일신바이오

₩1,009▲ ₩4 (0.40%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩4.2B₩2.5B₩4.2B₩4.9B₩3.5B₩1.9B₩3.9B₩2.6B
Cost of sales₩1.8B₩1.2B₩2.3B₩2B₩1.7B₩814M₩1.6B₩963M
Gross profit₩2.4B₩1.3B₩2B₩2.9B₩1.8B₩1.1B₩2.3B₩1.7B
Operating income₩1.5B₩454M₩1.1B₩1.9B₩1.1B₩443M₩1.2B₩375M
Net income₩1.6B₩975M₩1.5B₩1.9B₩742M₩662M₩1.9B₩1.1B
Net income to shareholders₩1.6B₩975M₩1.5B₩1.9B₩742M₩662M₩1.9B₩1.1B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩74B₩73B₩69B₩67B₩65B₩64B₩64B₩62B
Current assets₩62B₩60B₩55B₩54B₩52B₩50B₩50B₩48B
Cash and equivalents₩2.7B₩1.7B₩2B₩1.4B₩1.5B₩1.3B₩1.7B₩2.7B
Total liabilities₩6.7B₩7.3B₩3.8B₩4B₩3.8B₩3.5B₩3.5B₩3.3B
Current liabilities₩6.7B₩7.3B₩3.7B₩3.7B₩3.8B₩3.4B₩3.5B₩3B
Total equity₩67B₩65B₩65B₩64B₩62B₩61B₩60B₩59B
Shareholders' equity₩67B₩65B₩65B₩64B₩62B₩61B₩60B₩59B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩431M₩3.5B₩1.6B₩2.5B₩1.1B₩75M₩2.3B−₩237M
Capital spending₩308,182₩0₩40M−₩42M₩1.7M₩6M——
Free cash flow₩431M₩3.5B₩1.5B₩2.4B₩1.1B₩69M₩2.3B−₩237M
Dividends paid——₩0₩0——₩0₩0

Consolidated where available. Amounts in won.

Also known as: ilShinbiobase / 일신바이오 / 068330 / KRX:068330

Source: KRX statistical information